Barrington Research Has Bearish Forecast for DLB Q1 Earnings

Dolby Laboratories (NYSE:DLB) – Research analysts at Barrington Research dropped their Q1 2026 earnings per share (EPS) estimates for Dolby Laboratories in a report issued on Wednesday, November 19th. Barrington Research analyst P. Sholl now anticipates that the electronics maker will post earnings of $0.63 per share for the quarter, down from their prior forecast of $0.68. Barrington Research has a “Outperform” rating and a $95.00 price objective on the stock. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.94 per share. Barrington Research also issued estimates for Dolby Laboratories’ Q2 2026 earnings at $1.04 EPS, Q3 2026 earnings at $0.70 EPS, Q4 2026 earnings at $0.76 EPS and FY2026 earnings at $3.14 EPS.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The business had revenue of $307.02 million for the quarter, compared to the consensus estimate of $305.76 million. During the same quarter last year, the business posted $0.61 EPS. The business’s revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS.

Several other equities analysts have also commented on the stock. Rosenblatt Securities lowered their price target on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Wednesday. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Thursday, November 13th. Robert W. Baird initiated coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They issued a “neutral” rating and a $74.00 price target on the stock. Tigress Financial lifted their price target on Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a report on Friday, August 15th. Finally, Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Dolby Laboratories has an average rating of “Moderate Buy” and an average target price of $92.00.

Dolby Laboratories Price Performance

Shares of NYSE DLB opened at $67.52 on Friday. The firm has a market capitalization of $6.47 billion, a PE ratio of 24.73 and a beta of 0.97. Dolby Laboratories has a 1-year low of $64.02 and a 1-year high of $89.66. The business’s fifty day moving average price is $68.59 and its two-hundred day moving average price is $72.35.

Dolby Laboratories Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd will be given a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.1%. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date is Tuesday, December 2nd. Dolby Laboratories’s payout ratio is currently 54.75%.

Insider Transactions at Dolby Laboratories

In other news, CEO Kevin J. Yeaman sold 25,000 shares of Dolby Laboratories stock in a transaction on Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total transaction of $1,721,750.00. Following the transaction, the chief executive officer directly owned 114,725 shares in the company, valued at approximately $7,901,110.75. This trade represents a 17.89% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 38.39% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. First Horizon Corp bought a new stake in Dolby Laboratories in the third quarter worth about $25,000. Hantz Financial Services Inc. grew its stake in shares of Dolby Laboratories by 166.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after purchasing an additional 220 shares during the last quarter. Cheviot Value Management LLC acquired a new position in shares of Dolby Laboratories in the 1st quarter worth approximately $27,000. MAI Capital Management raised its holdings in shares of Dolby Laboratories by 87.1% in the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after purchasing an additional 162 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in Dolby Laboratories during the first quarter valued at approximately $29,000. Institutional investors own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.